science

MolMed

MolMed is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand MolMed rather than just read about it. In short: MOLMED is an Italian biotechnology company founded in 1996 in Milan, where it has its registered and operational headquarters. It originally operated as a contract manufacturing organization, and provided other services for companies developing gene therapy and cell therapy products.

Key takeaways

MolMed belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect MolMed to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of MolMed from memory before moving on to harder problems.

Reference excerpt

MOLMED is an Italian biotechnology company founded in 1996 in Milan, where it has its registered and operational headquarters. It originally operated as a contract manufacturing organization, and provided other services for companies developing gene therapy and cell therapy products. In 2000, the company changed its business model and started to develop products of its own. It is now focused on research, development, and clinical validation of innovative therapies for the treatment of cancer. Its headquarters are located within the San Raffaele Biomedical Science Park (which includes the hospital of the same name, a research institute, and a private university), and an operational site in Bresso at OpenZone.

History The company was founded by Claudio Bordignon in 1996 as a joint venture between Science Park Raf and Boehringer Mannheim. During its first three years, during which the acquisition of Boehringer Mannheim by Roche took place, Roche sold its stake in MolMed to the venture capital fund EDCP. In 2001, MolMed signed an agreement with San Raffaele Hospital which gave MolMed an option to license any gene therapy or cell therapy invention made at the hospital in the fields of cancer and HIV. In 2002 the company acquired and incorporated Genera S.p.A., the research company of the San Raffaele Scientific Institute, and in 2004 three major Italian private investors joined MolMed's shareholder base: Fininvest, Herule Finance (later H-Equity S.r.l.), and La Leonardo Finanziaria (now Delfin S.à r.l.), through a capital increase of 20 million euros. In 2006 a capital increase of 16 million euros took place and in 2007 another of 10 million euros, leading up to the company's stock market listing in 2008 with a public offering (IPO) of 25% of its shares, through which 56 million euros were raised before expenses. The total number of shares issued was 105,207,808 (100% ordinary shares without nominal value). Finally, in 2010 a rights issue capital increase was carried out (58 million euros before expenses), with one new share issued for each share outstanding, for a total of 210,415,616 shares issued (100% ordinary shares without nominal value). In early 2015, MolMed partnered with GlaxoSmithKline related to GSK's acquisition of Strimvelis; MolMed had been involved in the early development of the product. In March 2020, Fininvest, the reference shareholder with 23.13%, announced its intention to participate in the total takeover bid of the Japanese Agc (Mitsubishi) at the price of 0.518 euros per share, with a 110% premium compared to the price recorded in the session of the previous day (0.24 euro). As of 2020, the company is known as AGC Biologics. In March 2020 Fininvest, the reference shareholder with 23.13%, announced that it would join the full takeover bid by the Japanese company AGC (Mitsubishi) at a price of €0.518 per share, with a premium of 110% compared with the price recorded in the previous trading session (€0.24). The offer valued the entire company at €240 million. For Fininvest this represented a capital gain of €30 million. H-Invest (1.52%), owned by Ennio Doris, also joined the transaction. At the end of the takeover bid the company's shares were delisted.

Products MolMed's product portfolio includes antitumor therapeutics in clinical and preclinical development:

TK, a cell therapy that allows bone marrow transplantation from donors partially compatible with the patient. On 24 June 2016 it obtained a positive opinion from the CHMP for conditional marketing authorization for Zalmoxis (the commercial name of TK) in Europe. On 18 August 2016 Zalmoxis received conditional marketing authorization (Conditional Marketing Authorization – CMA) from the European Commission as an adjunct therapy to haploidentical hematopoietic stem cell transplantation in adult patients suffering from leukemia and other high-risk blood cancers. NGR-hTNF, an agent targeting tumor blood vessels, in phase III trials for malignant pleural mesothelioma and in phase II trials for six other indications: colorectal, liver, small-cell lung, non-small-cell lung, and ovarian carcinomas, as well as soft tissue sarcomas.

References

External links Official website

Illustrations

Worked examples

Example 1 — a first encounter with MolMed

Start with the simplest possible case. Write down what MolMed claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to MolMed before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about MolMed ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of MolMed

In research: MolMed appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses MolMed in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: MolMed is common in secondary-school and first-year university syllabi. It links to neighbouring topics Biotechnology companies, Companies based in Milan, Companies established in 1996, so understanding it makes those chapters shorter.
In everyday life: Look for MolMed outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “MolMed” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study MolMed in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what MolMed means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain MolMed out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is MolMed in simple terms?

Why does MolMed matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study MolMed?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on MolMed.